The session will feature an expert marketing and science panel including Christopher Shanahan, MS, Global Programme Manager, Frost & Sullivan, Melinda Fernyhough Culver DVM, PhD, Director of Scientific Affairs, OmniActive Health Technologies and Jonathan Oliver, PhD, Assistant Professor at Texas Christian University.
During the session, attendees will gain insight into the current challenges and critiques affecting curcumin’s legitimacy as a dietary supplement.
“Curcumin’s meteoric rise in popularity is the result of high consumer interest and a large body of research supporting its efficacy and safety,” said Lynda M. Doyle, Sr VP, OmniActive Health Technologies.
“This webinar offers guidelines for building substantiation through well-designed, human clinical trials that provide focused formula solutions for consumers and to reinforce curcumin’s continued success in the market.”
For more details or to register.